ANNUAL EXPOSURE OF THE SWISS POPULATION FROM MEDICAL IMAGING IN 2018.


Journal

Radiation protection dosimetry
ISSN: 1742-3406
Titre abrégé: Radiat Prot Dosimetry
Pays: England
ID NLM: 8109958

Informations de publication

Date de publication:
12 Oct 2021
Historique:
received: 31 10 2020
revised: 18 12 2020
accepted: 12 01 2021
pubmed: 2 3 2021
medline: 15 10 2021
entrez: 1 3 2021
Statut: ppublish

Résumé

Nationwide surveys on radiation dose to the population from medical imaging are recommended in order to follow trends in population exposure. The goal of the 2018 survey was to investigate the current exposure. The invoice coding information was collected in five university hospitals and large clinics. To improve the estimation of the effective dose delivered in computed tomography (CT), we collected dose data from different Dose Archiving Communication Systems. On average, we found that 1.2 radiological examinations per year and per inhabitant were performed. Dental radiography was the most frequent examination (48% of all the X-ray examinations), followed by conventional radiography (36%) and CT (11%). The average annual effective dose was estimated to be 1.48 mSv per inhabitant, with CT representing 64% of that dose. Our results show that the exposure of the Swiss population from medical imaging has remained stable since 2013, despite a 15% increase in the number of CT examinations.

Identifiants

pubmed: 33647105
pii: 6153488
doi: 10.1093/rpd/ncab012
pmc: PMC8507460
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

289-295

Subventions

Organisme : Swiss Federal Office of Public Health

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press.

Références

Radiology. 2010 Oct;257(1):158-66
pubmed: 20851940
Wien Klin Wochenschr. 2020 Oct;132(19-20):563-571
pubmed: 31612323
Radiat Prot Dosimetry. 2016 Jun;169(1-4):221-4
pubmed: 26541187
Swiss Med Wkly. 2012 Sep 26;142:w13677
pubmed: 23015536
Health Phys. 2019 Feb;116(2):126-128
pubmed: 30585951
J Nucl Med. 2010 Oct;51(10):1592-9
pubmed: 20847168
Insights Imaging. 2011 Apr;2(2):161-9
pubmed: 23099842
Z Med Phys. 2018 Dec;28(4):265-275
pubmed: 29463428
N Engl J Med. 2007 Nov 29;357(22):2277-84
pubmed: 18046031
EJNMMI Phys. 2019 Jan 11;6(1):2
pubmed: 30631980
J Nucl Med. 2011 Mar;52(3):485-91
pubmed: 21321275
Health Phys. 2012 Mar;102(3):263-70
pubmed: 22420018
Radiologe. 2017 Jul;57(7):555-562
pubmed: 28361179

Auteurs

Anaïs Viry (A)

Institute of Radiation Physics (IRA), Lausanne University Hospital, Lausanne, Switzerland.

Julie Bize (J)

Institute of Radiation Physics (IRA), Lausanne University Hospital, Lausanne, Switzerland.

Philipp R Trueb (PR)

Radiation Protection Division, Swiss Federal Office of Public Health, Bern, Switzerland.

Barbara Ott (B)

Radiation Protection Division, Swiss Federal Office of Public Health, Bern, Switzerland.

Damien Racine (D)

Institute of Radiation Physics (IRA), Lausanne University Hospital, Lausanne, Switzerland.

Francis R Verdun (FR)

Institute of Radiation Physics (IRA), Lausanne University Hospital, Lausanne, Switzerland.

Régis LeCoultre (R)

University of Health Sciences (HESAV), University of Applied Sciences Western Switzerland (HES-SO), Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH